| Literature DB >> 36005517 |
Tao Chen1, Wencong Yang1, Taobo Li1, Yihao Yin1, Yufeng Liu1, Bo Wang1, Zhigang She1.
Abstract
Four new compounds including three andrastin-type meroterpenoids hemiacetalmeroterpenoids A-C (1-3), and a drimane sesquiterpenoid astellolide Q (15), together with eleven known compounds (4-14) were isolated from the cultures of the marine-derived fungus Penicillium sp. N-5, while compound 14 was first isolated from a natural source. The structures of the new compounds were determined by analysis of detailed spectroscopic data, and the absolute configurations were further decided by a comparison of the experimental and calculated ECD spectra. Hemiacetalmeroterpenoid A (1) possesses a unique and highly congested 6,6,6,6,5,5-hexa-cyclic skeleton. Moreover, the absolute configuration of compound 14 was also reported for the first time. Compounds 1, 5 and 10 exhibited significant antimicrobial activities against Penicillium italicum and Colletrichum gloeosporioides with MIC values ranging from 1.56 to 6.25 μg/mL.Entities:
Keywords: andrastin-type meroterpenoids; antimicrobials activities; drimane sesquiterpenoid; marine-derived fungus
Mesh:
Substances:
Year: 2022 PMID: 36005517 PMCID: PMC9410149 DOI: 10.3390/md20080514
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Structure of compounds 1–15.
1H NMR (600 MHz) and 13C NMR (150 MHz) of 1-3 in CD3OD.
| Position | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| 1 | 34.7 (CH2) | 1.42, m | 35.3 (CH2) | 1.12, m | 34.8 (CH2) | 1.15, m |
| 2 | 30.2 (CH2) | 1.85, m | 30.3 (CH2) | 1.74, m | 30.1 (CH2) | 1.76, m |
| 3 | 99.8 (C) | 99.5 (C) | 99.5 (C) | |||
| 4 | 41.4 (C) | 41.3 (C) | 41.3 (C) | |||
| 5 | 49.1 (CH) | 1.47, m | 50.9 (CH) | 1.33, m | 51.4 (CH) | 1.21, m |
| 6 | 19.4 (CH2) | 1.62, m | 20.5 (CH2) | 1.55, m | 20.4 (CH2) | 1.62, m |
| 7 | 32.3 (CH2) | 1.94, m | 32.5 (CH2) | 2.07, m | 32.9 (CH2) | 1.94, m |
| 8 | 40.2 (C) | 42.4 (C) | 41.9 (C) | |||
| 9 | 150.1 (C) | 48.5 (CH) | 1.89, t (2.7) | 48.6 (CH) | 1.98, t (2.7) | |
| 10 | 38.5 (C) | 36.3 (C) | 36.3 (C) | |||
| 11 | 127.2 (CH) | 5.63, s | 124.2 (CH) | 5.42, m | 126.0 (CH) | 5.60, m |
| 12 | 77.4 (C) | 137.7 (C) | 133.7 (C) | |||
| 13 | 54.4 (C) | 57.5 (C) | 60.6 (C) | |||
| 14 | 73.4 (C) | 69.7 (C) | 69.2 (C) | |||
| 15 | 203.7 (C) | 190.7 (C) | 171.9 (C) | |||
| 16 | 76.7 (C) | 113.5 (C) | 131.9 (C) | |||
| 17 | 203.8 (C) | 201.4 (C) | 202.1 (C) | |||
| 18 | 7.9 (CH3) | 1.19, s | 6.6 (CH3) | 1.57, s | 8.8 (CH3) | 1.55, s |
| 19 | 11.0 (CH3) | 1.33, s | 18.0 (CH3) | 1.18, s | 17.4 (CH3) | 1.20, s |
| 20 | 24.2 (CH3) | 1.23, s | 20.2 (CH3) | 1.82, s | 19.1 (CH3) | 1.75, s |
| 21 | 74.4 (CH2) | 3.55, d (7.6) | 68.6 (CH2) | 3.81, d (9.0) | 68.5 (CH2) | 3.82, d (8.9) |
| 22 | 27.2 (CH3) | 1.07, s | 27.9 (CH3) | 1.04, s | 27.9 (CH3) | 1.07, s |
| 23 | 18.9 (CH3) | 1.04, s | 18.9 (CH3) | 1.01, s | 18.8 (CH3) | 1.03, s |
| 24 | 25.9 (CH3) | 1.49, s | 16.7 (CH3) | 1.19, s | 16.5 (CH3) | 1.24, s |
| 25 | 169.3 (C) | 172.6 (C) | 170.9 (C) | |||
| 26 | 52.5 (CH3) | 3.60, s | 51.9 (CH3) | 3.56,s | 52.4 (CH3) | 3.59,s |
| Ac-CH3 | 21.2 (CH3) | 2.36, s | ||||
| Ac-OCO | 167.3 (C) | |||||
Figure 2Key HMBC and COSY correlations of 1–3 and 15.
Figure 3Key NOE correlations of 1–3 and 14–15.
Figure 4ECD spectra of compounds 1 (A), 2 and 3 (B), 14 and 15 (C) in CH3OH.
1H NMR (400 MHz) and 13C NMR (100 MHz) of 15 in CD3OD.
| Position |
| Position |
| ||
|---|---|---|---|---|---|
| 1 | 35.3 (CH2) | 1.45, m | 10 | 44.2 (C) | |
| 2 | 19.5 (CH2) | 1.54, m | 11 | 71.8 (CH2) | 5.00, d (17.7) |
| 3 | 37.0 (CH2) | 1.16, m | 12 | 177.0 (C) | |
| 4 | 39.3 (C) | 13 | 68.1 (CH2) | 4.44, d (11.2) | |
| 5 | 56.4 (CH) | 1.74, s | 14 | 28.1 (CH3) | 1.16, s |
| 6 | 63.6 (CH) | 4.61, d (11.0) | 15 | 65.7 (CH2) | 3.76, d (12.0) |
| 7 | 33.0 (CH2) | 2.34, d, (18.9) | Ac-CH3 | 20.8 (CH3) | 2.08, s |
| 8 | 124.0 (C) | Ac-OCO | 173.1 (C) | ||
| 9 | 169.0 (C) |
Antimicrobial activity of compounds 1–15.
| Microbia | Methicillin-Resistent | ||||||
|---|---|---|---|---|---|---|---|
| Compound | |||||||
|
| 25 | 6.25 | >50 | >50 | 6.25 | 6.25 | |
|
| >50 | >50 | 25 | >50 | 50 | >50 | |
|
| >50 | >50 | >50 | >50 | 50 | >50 | |
|
| >50 | >50 | >50 | >50 | >50 | >50 | |
|
| 50 | 25 | 25 | >50 | 1.56 | 3.13 | |
|
| >50 | 25 | 50 | >50 | 12.50 | 25 | |
|
| >50 | >50 | >50 | >50 | 25 | 25 | |
|
| >50 | >50 | >50 | >50 | >50 | >50 | |
|
| >50 | >50 | >50 | >50 | >50 | >50 | |
|
| 25 | 12.50 | 25 | 3.13 | 6.25 | 6.25 | |
|
| >50 | >50 | >50 | >50 | >50 | >50 | |
|
| >50 | >50 | >50 | >50 | >50 | >50 | |
|
| 50 | >50 | >50 | >50 | 50 | >50 | |
|
| >50 | >50 | >50 | >50 | >50 | >50 | |
|
| >50 | >50 | >50 | >50 | 25 | 25 | |
| Ampicillin | 0.13 | 0.13 | 0.07 | 0.13 | - | - | |
| Ketoconazole | - | - | - | - | 0.78 | 0.78 | |
a: The deviation value of three parallel experiments; -: No test.